-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2025-01-29
FJDMLX:NMF-FJDMLX (USD)
MUTUAL FUND | Others |
Last Closing
USD 12.6013Change
-0.08 (-0.63)%Market Cap
N/AVolume
N/AAnalyst Target
N/AN/A
Verdict
Values as of: 2025-01-29
MUTUAL FUND | Others |
Last Closing
USD 12.6013Change
-0.08 (-0.63)%Market Cap
N/AVolume
N/AAnalyst Target
N/AN/A
Verdict
Currency:
Country :
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
VRGWX | Vanguard Russell 1000 Growth I.. |
-5.41 (-0.66%) |
USD 26.28B |
XMDYX | Mid Cap SPDR 400 Trust Series .. |
-2.39 (-0.40%) |
USD 19.32B |
VRTIX | Vanguard Russell 2000 Index Fu.. |
-0.87 (-0.25%) |
USD 10.02B |
VRVIX | Vanguard Russell 1000 Value In.. |
-0.61 (-0.18%) |
USD 9.85B |
VRNIX | Vanguard Scottsdale Funds - Va.. |
-2.36 (-0.44%) |
USD 7.05B |
VRTTX | Vanguard Russell 3000 Index Fu.. |
-2.25 (-0.43%) |
USD 3.51B |
XAODX | Alpine Total Dynamic Dividend .. |
-0.01 (-0.10%) |
USD 2.09B |
XNUVX | Nuveen Municipal Value Fd Inc |
-0.01 (-0.11%) |
USD 2.06B |
VRTGX | Vanguard Russell 2000 Growth I.. |
-0.60 (-0.15%) |
USD 1.19B |
XJPCX | Nuveen Preferred Income Opport.. |
+0.01 (+0.13%) |
USD 0.99B |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
URNP:LSE | Sprott Uranium Miners UCI.. | 5.40 % | 0.00 % |
+20.30 (+4.42%) |
USD 0.25B |
U3O8:F | HANetf ICAV - Sprott Uran.. | 5.30 % | 0.00 % |
+0.21 (+4.42%) |
N/A |
URNU:SW | Global X Uranium UCITS ET.. | 4.44 % | 0.00 % |
+0.63 (+4.42%) |
USD 0.21B |
URNG:LSE | Global X Uranium UCITS ET.. | 4.23 % | 0.00 % |
+0.55 (+4.42%) |
USD 0.21B |
URA | Global X Uranium ETF | 3.46 % | 0.72 % |
+0.78 (+4.42%) |
USD 3.45B |
ATOM:AU | Global X Uranium ETF | 3.40 % | 0.00 % |
+0.23 (+4.42%) |
N/A |
HURA:CA | Global X Uranium Index ET.. | 0.00 % | 0.00 % |
+1.07 (+4.42%) |
CAD 0.09B |
Market Performance vs. Industry/Classification (Others) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Trailing 12 Months | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Trailing 5 Years | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | N/A | N/A | N/A | N/A | N/A | ||
Risk Adjusted Return | N/A | N/A | N/A | N/A | N/A | ||
Market Capitalization | N/A | N/A | N/A | N/A | N/A |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
There is nothing we particularly like
There is nothing we particularly dislike